GSK plc Investments In Subsidiaries Joint Ventures And Associates
GSK plc (GLAXF) had Investments In Subsidiaries Joint Ventures And Associates of GBP 89.00 million as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates · last filed 2026-03-06
- 2025-12-31: Investments In Subsidiaries Joint Ventures And Associates 89.00M GBP.
- 2024-12-31: Investments In Subsidiaries Joint Ventures And Associates 96.00M GBP.
- 2023-12-31: Investments In Subsidiaries Joint Ventures And Associates 55.00M GBP.
- 2022-12-31: Investments In Subsidiaries Joint Ventures And Associates 74.00M GBP.
| Period end | Investments In Subsidiaries Joint Ventures And Associates |
|---|---|
| 2025-12-31 | 89.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 96.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 55.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 74.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 88.00M GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 364.00M GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | 314.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 236.00M GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | 183.00M GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | 263.00M GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 207.00M GBP 20-F/A · filed 2018-03-20 |